United Kingdom of Great Britain and Northern Ireland vs Palestine, State of: Hepatitis B surface antigen (HBsAg) prevalence
United Kingdom of Great Britain and Northern Ireland
0.0%
in 2024
Palestine, State of
0.0%
in 2024
United Kingdom of Great Britain and Northern Ireland rank
132nd
Palestine, State of rank
132nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- United Kingdom of Great Britain and Northern Ireland
- Palestine, State of
How they compare
United Kingdom of Great Britain and Northern Ireland currently reports 0.0% against 0.0% in Palestine, State of, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Palestine, State of ahead.
United Kingdom of Great Britain and Northern Ireland ranks 132nd and Palestine, State of ranks 132nd of 194 countries.
United Kingdom of Great Britain and Northern Ireland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | United Kingdom of Great Britain and Northern Ireland | Palestine, State of | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.0% | 0.0% | United Kingdom of Great Britain and Northern Ireland |
| 2020s | 0.0% | 0.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, United Kingdom of Great Britain and Northern Ireland or Palestine, State of?
- United Kingdom of Great Britain and Northern Ireland, at 0.0% against 0.0% in Palestine, State of as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between United Kingdom of Great Britain and Northern Ireland and Palestine, State of?
- 0.0%, with United Kingdom of Great Britain and Northern Ireland ahead.
- How many years of comparable data are there for United Kingdom of Great Britain and Northern Ireland and Palestine, State of?
- 10 years are reported by both, from 2015 to 2024.
- How do United Kingdom of Great Britain and Northern Ireland and Palestine, State of rank globally for hepatitis b surface antigen (hbsag) prevalence?
- United Kingdom of Great Britain and Northern Ireland ranks 132nd and Palestine, State of ranks 132nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.